Global Startup Awards Nominate Bioscience Equity Partners for Investor of the Year
Bioscience Equity Partners is proud to announce its nomination for Investor of the Year at the 11th edition of the Global Startup Awards, one of the world’s leading platforms recognizing excellence across global innovation ecosystems.
The nomination recognizes BEP’s disciplined, science-led investment mandate and its commitment to building life-science companies with strong governance, institutional alignment, and long-term capital strategy, prioritizing scientific rigor over market momentum.
Commenting on the recognition, George Syrmalis, Founder and CEO of BEP, noted that meaningful progress in biotechnology is driven by rigorous science and disciplined capital management, not short-term hype, an approach that continues to define the firm’s global investment philosophy.
As the awards progress, regional winners will advance to the Global Grand Finale in Valletta, Malta (May 7–8, 2026), bringing together leading investors and founders from across the global life-sciences ecosystem.
This nomination reinforces BEP’s long-standing mission: to back serious biotechnology, med-tech, and digital health companies through uncompromising execution and institutional-grade investment standards.
